![]() |
市場調查報告書
商品編碼
1938575
糖尿病襪市場 - 全球產業規模、佔有率、趨勢、機會及預測(依產品類型、材料、銷售管道、地區及競爭格局分類,2021-2031年)Diabetic Socks Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Material Used, By Sales Channel, By Region & Competition, 2021-2031F |
||||||
全球糖尿病襪市場預計將從 2025 年的 2.7091 億美元成長到 2031 年的 4.0045 億美元,複合年成長率為 6.73%。
這些特製襪子採用吸濕排汗布料、無縫襪頭和寬鬆襪口,旨在促進血液循環,預防糖尿病患者足部潰瘍。其市場成長主要受人口老化(易患神經病變)以及全球糖尿病患者人數不斷增加(需要足部預防護理)的推動。根據國際糖尿病聯盟 (IDF) 2024 年的報告,屆時全球約有 5.89 億成年人將患有糖尿病,凸顯了防護鞋履對於避免截肢等嚴重後果的緊迫性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 2.7091億美元 |
| 市場規模:2031年 | 4.045億美元 |
| 複合年成長率:2026-2031年 | 6.73% |
| 成長最快的細分市場 | 電子商務 |
| 最大的市場 | 北美洲 |
然而,與普通襪子相比,這些特殊產品高成本,這阻礙了市場成長。高昂的價格抑制了消費者的購買意願,尤其是在低收入地區,那裡的居民可支配收入有限,且預防性醫用紡織品的保險覆蓋不足。因此,儘管這些產品具有公認的健康益處,但經濟因素仍然是推廣應用的一大障礙,限制了其市場滲透率的進一步提高。
全球糖尿病盛行率的快速成長是推動該市場發展的主要因素,顯著擴大了需要足部預防護理的患者群體。隨著診斷率的上升,對促進血液循環和緩解壓力的專用襪的需求也相應成長,這些襪子對於日常足部健康管理和潰瘍預防至關重要。根據2024年11月發表在《柳葉刀》上的一項研究,全球糖尿病成人患者人數將達到8.28億,超過先前的估計值。糖尿病患者數量的指數級成長直接推動了對用於預防慢性下肢併發症的防護襪的需求。
同時,人們對神經病變和足部衛生不良危害的認知不斷提高,加速了相關產品的上市。醫療保健專業人員積極推薦糖尿病襪作為預防潰瘍和截肢的關鍵措施,尤其是在高風險族群中。嚴重併發症的統計數據凸顯了其緊迫性。例如,英國糖尿病協會在2024年2月報告稱,英格蘭每周有超過180例與糖尿病相關的截肢手術。此外,人口老化帶來的脆弱性也支撐了市場。正如英國國家老齡委員會在2024年2月指出,約有29.2%的65歲及以上成年人患有糖尿病,這確保了老年人群對糖尿病襪的穩定需求。
醫用專用紡織品的高成本是限制全球糖尿病襪市場成長的主要障礙。與普通襪子不同,糖尿病襪需要複雜的生產流程,例如吸濕排汗布料混紡、無縫襪頭設計以及寬鬆的襪口。這些技術要求增加了生產成本,導致零售價格上漲,從而疏遠了對價格敏感的消費者。這種價格差異對患者構成了重大負擔,尤其是在中低收入地區,他們必須自費承擔足部預防保健費用,而無法獲得醫療保險。
糖尿病本身帶來的巨大經濟負擔加劇了治療費用負擔問題,消耗了原本可用於輔助治療的財政資源。公立和私立醫療機構預算的壓力迫使人們在基本藥物和預防性輔助用品之間做出艱難抉擇。根據國際糖尿病聯盟預測,2024年,全球與糖尿病相關的醫療保健費用將至少達到1兆美元。如此巨大的經濟負擔限制了病患的購買力,阻礙了市場滲透,迫使人們優先考慮緊急醫療救治而非防護鞋。
智慧感測器技術的整合正在改變市場格局,使糖尿病襪從被動防護轉變為主動、即時疾病管理工具。製造商正在開發將微型感測器嵌入織物的技術,以追蹤足底壓力和溫度,在潰瘍形成之前及早發現發炎。這項創新吸引了大量投資。根據 TechFundingNews 2025 年 1 月報道,美國公司 Siren 已成功資金籌措950 萬美元,用於進一步開發其溫度監測襪。這一趨勢標誌著穿戴式醫療紡織品正與遠端患者監護系統相結合,以降低長期治療成本。
同時,抗菌奈米技術正逐漸成為產品差異化優勢,滿足了降低有下肢疾病史患者感染風險的迫切需求。為了抑制細菌和真菌的生長,製造商正在產品中添加銀或銅浸漬纖維,以破壞病原體的細胞膜。這種持續保護的重要性體現在疾病的持續性上。 2025年9月,Medscape指出,糖尿病足潰瘍的三年復發率約為58%,與進行性的復發率相當。因此,抗菌特性對於預防再次感染和維持高風險患者的長期緩解至關重要。
The Global Diabetic Socks Market is projected to expand from USD 270.91 Million in 2025 to USD 400.45 Million by 2031, reflecting a CAGR of 6.73%. These specialized socks utilizes moisture-wicking materials, seamless toes, and non-binding cuffs to enhance circulation and prevent ulcers in diabetic patients. Growth is largely driven by an aging demographic prone to neuropathy and a worldwide increase in diabetes cases, which necessitates preventive foot care. The International Diabetes Federation reported in 2024 that roughly 589 million adults globally live with diabetes, highlighting the urgent need for protective footwear to avert serious outcomes like amputation.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 270.91 Million |
| Market Size 2031 | USD 400.45 Million |
| CAGR 2026-2031 | 6.73% |
| Fastest Growing Segment | E-Commerce |
| Largest Market | North America |
However, market growth faces hurdles due to the high cost of these specialized products relative to standard socks. This price premium acts as a deterrent, especially in low-income areas where disposable income is scarce and insurance coverage for preventive medical textiles is often lacking. Consequently, economic limitations persist as a significant obstacle to widespread adoption, preventing broader market penetration even though the health benefits are well-established.
Market Driver
The surging global prevalence of diabetes acts as the primary driver for this market, significantly widening the pool of patients who need preventive foot care. As diagnosis rates climb, there is a proportional increase in demand for specialized hosiery designed to enhance circulation and minimize constriction, which is vital for managing daily foot health and averting ulcers. A study published in The Lancet in November 2024 revealed that the global adult population living with diabetes has reached 828 million, surpassing earlier estimates. This dramatic rise in the diabetic population directly fuels the demand for protective footwear to prevent chronic complications in the lower limbs.
Concurrently, heightened awareness regarding neuropathy and the dangers of poor foot hygiene is accelerating product adoption. Healthcare providers are actively advocating for diabetic socks as a crucial defense against ulcers and amputations, especially for high-risk groups. The urgency is underscored by severe complication statistics; for instance, Diabetes UK reported in February 2024 that over 180 diabetes-related amputations occur weekly in England. The market is further supported by the aging population's vulnerability, as the National Council on Aging noted in February 2024 that roughly 29.2% of adults over 65 have diabetes, ensuring consistent demand from the geriatric sector.
Market Challenge
The high cost of specialized medical textiles stands as the main obstacle to the growth of the Global Diabetic Socks Market. Unlike standard hosiery, these socks necessitate complex manufacturing techniques to integrate features like moisture-wicking blends, seamless toe closures, and non-binding cuffs. These technical demands inflate production costs, leading to a retail price premium that discourages price-sensitive buyers. This price gap forms a significant barrier, particularly in low-to-middle-income regions where patients frequently must cover the cost of preventive foot care out-of-pocket without insurance assistance.
The issue of affordability is exacerbated by the substantial economic burden of the disease itself, which drains financial resources that might otherwise be spent on ancillary care. The pressure on both personal and public health budgets necessitates difficult choices between essential medications and preventive accessories. According to the International Diabetes Federation, global health expenditures related to diabetes reached at least USD 1 trillion in 2024. This massive financial strain limits the purchasing power of patients, restricting market penetration as individuals are forced to prioritize immediate medical treatments over protective footwear.
Market Trends
The market is being transformed by the integration of smart sensor technology, which evolves diabetic hosiery from passive protection into active, real-time disease management tools. Manufacturers are embedding microsensors into fabrics to track foot pressure and temperature, facilitating the early detection of inflammation prior to ulcer formation. This innovation is drawing substantial investment; as reported by TechFundingNews in January 2025, US-based company Siren secured USD 9.5 million to advance its temperature-monitoring socks. This trend highlights a shift toward linking wearable medical textiles with remote patient monitoring systems to lower long-term treatment costs.
Parallel to this, the use of antimicrobial nanotechnology is emerging as a key product differentiator, addressing the critical need to lower infection risks in patients with previous lower limb issues. To counter bacterial and fungal growth, manufacturers are incorporating silver and copper-infused fibers that disrupt pathogen cell membranes. The importance of such continuous protection is evident in the persistence of the condition; Medscape noted in September 2025 that the three-year recurrence rate for diabetic foot ulcers is around 58%, comparable to aggressive cancers. Thus, antimicrobial properties are becoming indispensable for preventing re-infection and maintaining long-term remission in high-risk patients.
Report Scope
In this report, the Global Diabetic Socks Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Diabetic Socks Market.
Global Diabetic Socks Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: